/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Clene Nanomedicine

Clene Nanomedicine

United States

The company is a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function.

Healthcare & Biotech

Clene Nanomedicine, based in United States, has 1 investor on file, among them SymBiosis Capital Management. Its site was last checked 7 Nov 2026: site answers.

clene.com

Investors

1 investor on file
InvestorEvidenceType
SymBiosis Capital ManagementPortfolio pageVenture capital

In the news

1 headline naming Clene Nanomedicine
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Applicationfinanznachrichten.deProduct

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from SymBiosis Capital Management

28 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

Aeovian PharmaceuticalsAeovian Pharmaceuticals develops small molecules to treat certain rare…Attivare TherapeuticsAttivare Therapeutics develops personalized cancer immunotherapy treat…Biosplice TherapeuticsThe company is developing an investigational drug candidate for osteoa…EnsomaEnsoma is an in vivo hematopoietic stem cell engineering company that …Fore BiotherapeuticsFore Biotherapeutics develops targeted therapies for treating cancers.

See SymBiosis Capital Management's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Clene Nanomedicine and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when SymBiosis Capital Management adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/clene.com/investors

# also
GET /v1/companies/clene.com
GET /v1/companies/clene.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing